催产素受体与G蛋白偶联受体激酶6(GRK6)基因单核苷酸多态性与催产素剂量需求及分娩结局的关联
研究前瞻性纳入482例≥36周引产孕妇,检测OXTR的18个和GRK6的7个标签单核苷酸多态性,分析其与催产素最大输注速率、总剂量、产程时长及分娩方式的关系。GRK6的rs2731664与产程时长相关(P=0.0014,AA型17.7小时 vs AC型20.2小时 vs CC型23.5小时)。OXTR和GRK6遗传变异与催产素需求量、产程时长及剖宫产风险相关。
要点
- OXTR的5个单核苷酸多态性与催产素最大输注速率名义显著相关,2个与总剂量相关。
- GRK6的rs2731664与产程时长相关(P=0.0014),AA型17.7小时 vs AC型20.2小时 vs CC型23.5小时。
- OXTR和GRK6变异与引产孕妇的催产素用量、产程时长及剖宫产风险相关。
核心结论
- OXTR和GRK6的遗传变异与足月引产孕妇的催产素需求量、产程时长及剖宫产风险相关。
- 作者认为,进一步研究后,药物基因组学方法可能有望用于制定个体化治疗,以改善引产孕妇的安全性和有效性结局。
研究设计与样本
- 前瞻性队列研究,纳入居住于北卡罗来纳州达勒姆县、参加健康妊娠健康婴儿队列研究的单胎孕妇。
- 对≥36周引产者用TaqMan法检测OXTR的18个和GRK6的7个标签单核苷酸多态性,共482例有DNA样本。
- 采用线性回归分析基因型与催产素最大输注速率、总剂量及产程时长的关系,逻辑回归分析分娩方式,采用后退选择控制混杂,加性遗传模型,所有模型纳入种族/民族,并用Bonferroni校正多重检验。
主要发现
- OXTR的5个单核苷酸多态性与催产素最大输注速率名义显著相关,2个与总剂量相关。
- OXTR的1个和GRK6的2个单核苷酸多态性与产程时长相关,其中rs2731664(GRK6)达到多重检验阈值(P=0.0014),AA型、AC型、CC型基因型的平均产程时长分别为17.7小时、20.2小时、23.5小时。
- OXTR的2个和GRK6的1个单核苷酸多态性与分娩方式名义显著相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. OBJECTIVE: The objective of this study was to determine whether genetic variation in the oxytocin receptor (OXTR) or in the gene encoding G protein-coupled receptor kinase 6 (GRK6), which regulates desensitization of the oxytocin receptor, could explain variation in oxytocin dosing and labor outcomes among women being induced near term. STUDY DESIGN: Pregnant women with a singleton gestation residing in Durham County, NC, were prospectively enrolled as part of the Healthy Pregnancy, Healthy Baby cohort study. Those women undergoing an induction of labor at 36 weeks or greater were genotyped for 18 haplotype-tagging single-nucleotide polymorphisms in OXTR and 7 haplotype-tagging single-nucleotide polymorphisms in GRK6 using TaqMan assays. Linear regression was used to examine the relationship between maternal genotype and maximal oxytocin infusion rate, total oxytocin dose received, and duration of labor. Logistic regression was used to test for the association of maternal genotype with mode of delivery. For each outcome, backward selection techniques were utilized to control for important confounding variables and additive genetic models were used. Race/ethnicity was included in all models because of differences in allele frequencies across populations, and Bonferroni correction for multiple testing was used. RESULTS: DNA was available from 482 women undergoing induction of labor at 36 weeks or greater. Eighteen haplotype-tagging single-nucleotide polymorphisms within OXTR and 7 haplotype-tagging single-nucleotide polymorphisms within GRK6 were examined. Five single-nucleotide polymorphisms in OXTR showed nominal significance with maximal infusion rate of oxytocin, and two single-nucleotide polymorphisms in OXTR were associated with total oxytocin dose received. One single-nucleotide polymorphism in OXTR and two single-nucleotide polymorphisms in GRK6 were associated with duration of labor, one of which met the multiple testing threshold (P = .0014, rs2731664 [GRK6], mean duration of labor, 17.7 hours vs 20.2 hours vs 23.5 hours for AA, AC, and CC genotypes, respectively). Three single-nucleotide polymorphisms, two in OXTR and one in GRK6, showed nominal significance with mode of delivery. CONCLUSION: Genetic variation in OXTR and GRK6 is associated with the amount of oxytocin required as well as the duration of labor and risk for cesarean delivery among women undergoing induction of labor near term. With further research, pharmacogenomic approaches may potentially be utilized to develop personalized treatment to improve safety and efficacy outcomes among women undergoing induction of labor.
引用
- Grotegut CA, Ngan E, Garrett ME, et al. The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes. Am J Obstet Gynecol. 2017. PMID: 28526450. doi:10.1016/j.ajog.2017.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。